These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34046357)

  • 41. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.
    Banias L; Jung I; Bara T; Fulop Z; Simu P; Simu I; Satala C; Gurzu S
    Oncol Lett; 2020 Feb; 19(2):1487-1495. PubMed ID: 31966075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
    Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
    Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
    Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
    Shi ZM; Wang L; Shen H; Jiang CF; Ge X; Li DM; Wen YY; Sun HR; Pan MH; Li W; Shu YQ; Liu LZ; Peiper SC; He J; Jiang BH
    Oncogene; 2017 May; 36(18):2577-2588. PubMed ID: 28192397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
    Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J
    Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.
    He X; Wei Y; Wang Y; Liu L; Wang W; Li N
    Onco Targets Ther; 2016; 9():1231-9. PubMed ID: 27094913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
    Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
    J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
    Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
    Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
    Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
    Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.
    Zhang M; Jabbari N; Satpathy M; Matyunina LV; Wang Y; McDonald LD; McDonald JF
    Cancer Lett; 2019 Sep; 459():168-175. PubMed ID: 31163194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.
    Chen JH; Zhou LY; Xu S; Zheng YL; Wan YF; Hu CP
    Cancer Cell Int; 2017; 17():64. PubMed ID: 28615992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
    Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
    J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.
    Wang WX; Yu HL; Liu X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6467-6477. PubMed ID: 31378886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
    Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
    Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.